3–5 g daily-dose design① Effective dose /30
The authorised EU claim is based on 3 g/day and ISSN maintenance is 3–5 g/day. 'Concentrated micro-dose' claims lack evidence.
Evidence:ISSN Position Stand 2017 (Kreider)Hultman 1996, J Appl Physiol
Creatine
The authorised EU claim is based on 3 g/day and ISSN maintenance is 3–5 g/day. 'Concentrated micro-dose' claims lack evidence.
Evidence:ISSN Position Stand 2017 (Kreider)Hultman 1996, J Appl Physiol
Synthesis byproducts such as DCD (dicyandiamide) and DHT (dihydrotriazine) have EFSA-recommended limits, and some commercial products have tested positive for DCD and heavy metals. (This DHT is unrelated to the hormone DHT.)
Evidence:ISSN Position Stand 2017 (Kreider)
Creatine itself is not prohibited, but contamination-based doping risk exists at the product level.
Evidence:ISSN Position Stand 2017 (Kreider)
Verified sources like Creapure (AlzChem) are specified at 99.9%+ purity with ultra-low byproducts — though what matters is the purity data itself, not the brand name.
Evidence:ISSN Position Stand 2017 (Kreider)
ISSN position: no form has proven superior to monohydrate. In a head-to-head RCT, buffered creatine showed no advantage; HCl lacks superiority RCTs and carries less creatine per gram (87.9% vs ~78%).
Evidence:ISSN Position Stand 2017 (Kreider)Jagim 2012, JISSN
Evidence for added benefit from sugars or 'absorption enhancers' is limited; carbohydrate co-ingestion may modestly aid retention but is not required.
Evidence:ISSN Position Stand 2017 (Kreider)
See how real products score against these criteria
View product comparison →